Multi-modal molecular imaging maps the correlation between tumour microenvironments and nanomedicine distribution Authors:

1 Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK 2 Department of Chemistry, Technical University of Munich, Garching, Germany 3 Bioscience, Discovery, Oncology R&D, AstraZeneca, Cambridge, UK 4 Institute of Medical Bioinformatics and Biostatistics, University of Marburg, Germany 5 Translational Pathology & Biomarker Analysis, Translational Medicine, R&D Oncology, AstraZeneca, Gaithersburg, MD, USA 6 Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Cambridge, UK 7 DMPK, Oncology R&D, AstraZeneca, Cambridge, UK 8 National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI), National Physical Laboratory, Teddington, UK 9 Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK 10 Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield UK